Last update 01 Nov 2024

EGFR x TCRDV2

Basic Info

Related Targets
EGFRTCRDV2

Related

1
Drugs associated with EGFR x TCRDV2
SGN-EGFRd2
Target
EGFR x TCRDV2
Mechanism
EGFR antagonists [+1]
Active Org.
Seagen Inc.Seagen Inc. [+1]
Originator Org.
LAVA Therapeutics NVLAVA Therapeutics NV
Active Indication
Colorectal Cancer [+4]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with EGFR x TCRDV2
NCT05983133 / RecruitingPhase 1
A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors
100 Clinical Results associated with EGFR x TCRDV2
Login to view more data
100 Translational Medicine associated with EGFR x TCRDV2
Login to view more data
0 Patents (Medical) associated with EGFR x TCRDV2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free